Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Schemas01:42

Schemas

12.3K
A schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.
12.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteogenomic profiling of soft tissue leiomyosarcoma reveals distinct molecular subtypes with divergent outcomes and therapeutic vulnerabilities.

bioRxiv : the preprint server for biology·2025
Same author

Low-Grade Fibro-Osseous Lesions With Isolated Chromosome 12 Chromothripsis: A Distinct Entity Or a Low-Grade Central Osteosarcoma With a Novel Driver?

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

GLI1-altered mesenchymal tumors of the head and neck.

Seminars in diagnostic pathology·2025
Same author

Soft tissue sarcoma with MN1 gene fusions: a report of three cases with aggressive clinical behavior.

The Journal of pathology·2025
Same author

A Need for Multi-Institutional Collaboration for Deep Learning-Driven Assessment of Osteosarcoma Treatment Response.

The American journal of pathology·2025
Same author

Case report: Clinical and molecular features of renal gastrointestinal tumor.

Frontiers in oncology·2025
Same journal

Molecular Pathology in Contemporary Surgical Practice.

Surgical pathology clinics·2026
Same journal

Beyond Blood: Liquid biopsy assays for nonplasma body fluids.

Surgical pathology clinics·2026
Same journal

The Molecular Landscape of Ovarian Neoplasms: A Review.

Surgical pathology clinics·2026
Same journal

Clinically Relevant Molecular Pathology of Endometrial Cancer.

Surgical pathology clinics·2026
Same journal

Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Surgical pathology clinics·2026
Same journal

Oncogenicity and Therapeutic Implications of Molecular Biomarkers in Colorectal Carcinoma.

Surgical pathology clinics·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Fabrication of Myogenic Engineered Tissue Constructs
13:43

Fabrication of Myogenic Engineered Tissue Constructs

Published on: May 1, 2009

10.9K

Update on Myogenic Sarcomas.

Narasimhan P Agaram1

  • 1Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

Surgical Pathology Clinics
|February 3, 2019
PubMed
Summary
This summary is machine-generated.

Myogenic sarcomas, including rhabdomyosarcoma and leiomyosarcoma, are classified into subtypes based on clinical, pathological, and genetic features. This update emphasizes recent genetic findings and diagnostic approaches for these soft tissue tumors.

Keywords:
AlveolarEmbryonalFOXO1LeiomyosarcomaMYOD1PleomorphicRhabdomyosarcomaSpindle cell/Sclerosing

More Related Videos

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.3K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Related Experiment Videos

Last Updated: Jan 30, 2026

Fabrication of Myogenic Engineered Tissue Constructs
13:43

Fabrication of Myogenic Engineered Tissue Constructs

Published on: May 1, 2009

10.9K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

26.3K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.9K

Area of Science:

  • Oncology
  • Pathology
  • Genetics

Background:

  • Myogenic sarcomas encompass soft tissue tumors with skeletal muscle differentiation (rhabdomyosarcoma) and smooth muscle differentiation (leiomyosarcoma).
  • Rhabdomyosarcomas are prevalent in pediatric populations, while leiomyosarcomas are more common in adults.
  • Classification of rhabdomyosarcomas includes embryonal, alveolar, spindle cell/sclerosing, and pleomorphic subtypes, each with distinct morphology and genetic abnormalities.

Purpose of the Study:

  • To provide an update on myogenic sarcomas.
  • To highlight recent advancements in genetic findings related to these tumors.
  • To discuss the diagnostic approach for myogenic sarcomas.

Main Methods:

  • Review of clinico-pathologic features.
  • Analysis of genetic abnormalities.
  • Synthesis of recent literature on myogenic sarcomas.

Main Results:

  • Subtypes of rhabdomyosarcoma exhibit characteristic morphologies and genetic alterations.
  • Leiomyosarcomas have a different age distribution compared to rhabdomyosarcomas.
  • Recent genetic findings offer new insights into tumor classification and biology.

Conclusions:

  • Accurate classification of myogenic sarcomas relies on integrating clinico-pathologic and genetic data.
  • Understanding subtype-specific genetic abnormalities is crucial for diagnosis and potentially targeted therapies.
  • This review provides an updated perspective on the diagnosis and genetics of myogenic sarcomas.